Fabrication of Muco-Adhesive Oral Films by the 3D Printing of Hydroxypropyl Methylcellulose-Based Catechin-Loaded Formulations

1) Liaw CY, Guvendiren M. Current and emerging applications of 3D printing in medicine. <i>Biofabrication</i>, <b>9</b>, 024102 (2017).

2) Garcia J, Yang Z, Mongrain R, Leask RL, Lachapelle K. 3D printing materials and their use in medical education: a review of current technology and trends for the future. <i>BMJ Simul. Technol. Enhanc. Learn.</i>, <b>4</b>, 27–40 (2018).

3) Aran K, Chooljian M, Paredes J, Rafi M, Lee K, Kim AY, An J, Yau JF, Chum H, Conboy I, Murthy N, Liepmann D. An oral microjet vaccination system elicits antibody production in rabbits. <i>Sci. Transl. Med.</i>, <b>9</b>, eaaf6413 (2017).

4) Nagai N, Koyanagi E, Izumida Y, Liu J, Katsuyama A, Kaji H, Nishizawa M, Osumi N, Kondo M, Terasaki H, Mashima Y, Nakazawa T, Abe T. Long-term protection of genetically ablated rabbit retinal degeneration by sustained transscleral unoprostone delivery. <i>Invest. Ophthalmol. Vis. Sci.</i>, <b>57</b>, 6527–6538 (2016).

5) Filippou V, Tsoumpas C. Recent advances on the development of phantoms using 3D printing for imaging with CT, MRI, PET, SPECT, and ultrasound. <i>Med. Phys.</i>, <b>45</b>, e740–e760 (2018).

6) Diment LE, Thompson MS, Bergmann JHM. Clinical efficacy and effectiveness of 3D printing: a systematic review. <i>BMJ Open</i>, <b>7</b>, e016891 (2017).

7) Patra S, Young V. A review of 3D printing techniques and the future in biofabrication of bioprinted tissue. <i>Cell Biochem. Biophys.</i>, <b>74</b>, 93–98 (2016).

8) Nagarajan N, Dupret-Bories A, Karabulut E, Zorlutuna P, Vrana NE. Enabling personalized implant and controllable biosystem development through 3D printing. <i>Biotechnol. Adv.</i>, <b>36</b>, 521–533 (2018).

9) Alam MS, Akhtar A, Ahsan I, Shafiq-Un-Nabi S. Pharmaceutical product development exploiting 3D printing technology: conventional to novel drug delivery system. <i>Curr. Pharm. Des.</i>, <b>24</b>, 5029–5038 (2018).

10) Jamroz W, Kurek M, Lyszczarz E, Brniak W, Jachowicz R. Printing techniques: recent developments in pharmaceutical technology. <i>Acta Pol. Pharm.</i>, <b>74</b>, 753–763 (2017).

11) Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. <i>J. Control. Release</i>, <b>217</b>, 308–314 (2015).

12) Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. <i>Int. J. Pharm.</i>, <b>494</b>, 643–650 (2015).

13) Korte C, Quodbach J. 3D-printed network structures as controlled-release drug delivery systems: dose adjustment, API release analysis and prediction. <i>AAPS PharmSciTech</i>, <b>19</b>, 3333–3342 (2018).

14) Martinez PR, Goyanes A, Basit AW, Gaisford S. Influence of geometry on the drug release profiles of stereolithographic (SLA) 3D-printed tablets. <i>AAPS PharmSciTech</i>, <b>19</b>, 3355–3361 (2018).

15) Arafat B, Wojsz M, Isreb A, Forbes RT, Isreb M, Ahmed W, Arafat T, Alhnan MA. Tablet fragmentation without a disintegrant: a novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. <i>Eur. J. Pharm. Sci.</i>, <b>118</b>, 191–199 (2018).

16) Tagami T, Nagata N, Hayashi N, Ogawa E, Fukushige K, Sakai N, Ozeki T. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler. <i>Int. J. Pharm.</i>, <b>543</b>, 361–367 (2018).

17) Tagami T, Ando M, Nagata N, Goto E, Yoshimura N, Takeuchi T, Noda T, Ozeki T. Fabrication of naftopidil-loaded tablets using a semisolid extrusion-type 3D printer and the characteristics of the printed hydrogel and resulting tablets. <i>J. Pharm. Sci.</i>, <b>108</b>, 907–913 (2019).

18) Cubo N, Garcia M, Del Canizo JF, Velasco D, Jorcano JL. 3D bioprinting of functional human skin: production and <i>in vivo</i> analysis. <i>Biofabrication</i>, <b>9</b>, 015006 (2016).

19) Lee H, Chae S, Kim JY, Han W, Kim J, Choi Y, Cho DW. Cell-printed 3D liver-on-a-chip possessing a liver microenvironment and biliary system. <i>Biofabrication</i>, <b>11</b>, 025001 (2019).

20) Yi HG, Lee H, Cho DW. 3D printing of organs-on-chips. <i>Bioengineering</i>, <b>4</b>, 10 (2017).

21) Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. <i>Br. J. Oral Maxillofac. Surg.</i>, <b>46</b>, 198–206 (2008).

22) Russo G, Haddad R, Posner M, Machtay M. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. <i>Oncologist</i>, <b>13</b>, 886–898 (2008).

23) Jensen SB, Peterson DE. Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. <i>J. Oral Pathol. Med.</i>, <b>43</b>, 81–90 (2014).

24) Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea—a review. <i>J. Am. Coll. Nutr.</i>, <b>25</b>, 79–99 (2006).

25) Speer I, Preis M, Breitkreutz J. Novel dissolution method for oral film preparations with modified release properties. <i>AAPS PharmSciTech</i>, <b>20</b>, 7 (2019).

26) Yehia SA, El-Gazayerly ON, Basalious EB. Fluconazole mucoadhesive buccal films: <i>in vitro</i>/<i>in vivo</i> performance. <i>Curr. Drug Deliv.</i>, <b>6</b>, 17–27 (2009).

27) Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M, Rossi C. Development of mucoadhesive patches for buccal administration of ibuprofen. <i>J. Control. Release</i>, <b>99</b>, 73–82 (2004).

28) Wickström H, Palo M, Rijckaert K, Kolakovic R, Nyman JO, Määttänen A, Ihalainen P, Peltonen J, Genina N, de Beer T, Löbmann K, Rades T, Sandler N. Improvement of dissolution rate of indomethacin by inkjet printing. <i>Eur. J. Pharm. Sci.</i>, <b>75</b>, 91–100 (2015).

29) Raijada D, Genina N, Fors D, Wisaeus E, Peltonen J, Rantanen J, Sandler N. A step toward development of printable dosage forms for poorly soluble drugs. <i>J. Pharm. Sci.</i>, <b>102</b>, 3694–3704 (2013).

30) Janssen EM, Schliephacke R, Breitenbach A, Breitkreutz J. Drug-printing by flexographic printing technology—a new manufacturing process for orodispersible films. <i>Int. J. Pharm.</i>, <b>441</b>, 818–825 (2013).

31) Musazzi UM, Selmin F, Ortenzi MA, Mohammed GK, Franzé S, Minghetti P, Cilurzo F. Personalized orodispersible films by hot melt ram extrusion 3D printing. <i>Int. J. Pharm.</i>, <b>551</b>, 52–59 (2018).

32) Ehtezazi T, Algellay M, Islam Y, Roberts M, Dempster NM, Sarker SD. The application of 3D printing in the formulation of multilayered fast dissolving oral films. <i>J. Pharm. Sci.</i>, <b>107</b>, 1076–1085 (2018).

33) Jamróz W, Kurek M, Lyszczarz E, Szafraniec J, Knapik-Kowalczuk J, Syrek K, Paluch M, Jachowicz R. 3D printed orodispersible films with Aripiprazole. <i>Int. J. Pharm.</i>, <b>533</b>, 413–420 (2017).

34) Manasa B, Gudas GK, Sravanthi N, Madhuri RA, Lavanya Y, Pranitha C. Formulation and evaluation of mucoadhesive buccal patches of resperidone. <i>J. Chem. Pharm. Res.</i>, <b>2</b>, 866–872 (2010).

35) Takeuchi Y, Usui R, Ikezaki H, Tahara K, Takeuchi H. Characterization of orally disintegrating films: a feasibility study using an electronic taste sensor and a flow-through cell. <i>J. Drug Deliv. Sci. Tech.</i>, <b>39</b>, 104–112 (2017).

36) Kalyan S, Bansal M. Recent trends in the development of oral dissolving film. <i>Int. J. Pharm. Tech. Res.</i>, <b>4</b>, 725–733 (2012).

37) Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). <i>Adv. Drug Deliv. Rev.</i>, <b>48</b>, 139–157 (2001).

38) Scully C. Aphthous ulceration. <i>N. Engl. J. Med.</i>, <b>355</b>, 165–172 (2006).

39) Khaled SA, Alexander MR, Wildman RD, Wallace MJ, Sharpe S, Yoo J, Roberts CJ. 3D extrusion printing of high drug loading immediate release paracetamol tablets. <i>Int. J. Pharm.</i>, <b>538</b>, 223–230 (2018).